ICON partners with Anthropic to integrate Claude AI in clinical trials
Anthropic
ICON, a clinical research organisation, has partnered with Anthropic to integrate Claude AI into clinical trial processes. The deal aims to leverage AI for data analysis, patient monitoring, and regulatory compliance.
ICON, a global clinical research organisation, has announced a partnership with Anthropic to integrate the Claude AI model into clinical trial operations. The collaboration will focus on using AI to enhance data analysis, patient monitoring, and streamline regulatory compliance. This move is expected to improve efficiency and accuracy in clinical research, potentially accelerating drug development timelines.
Source: Anthropic (GNews) —
original